Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT02290431 · COMPLETED
Trial details
- NCT number
- NCT02290431
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-16
- Primary completion
- 2017-12-29
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.